Computing and Library Services - delivering an inspiring information environment

Acylation versus sulfonylation in the inhibition of elastase by 3-oxo-beta-sultams

Tsang, Wing Y., Ahmed, Naveed, Harding, Lindsay P., Hemming, Karl, Laws, Andrew P. and Page, Michael I. (2005) Acylation versus sulfonylation in the inhibition of elastase by 3-oxo-beta-sultams. Journal of the American Chemical Society, 127 (25). pp. 8946-8947. ISSN 1520-5126

Metadata only available from this repository.


-Sultams are the sulfonyl analogues of
-lactams, and 3-oxo- -sultams are both
-lactams and -sultams and, therefore,
susceptible to nucleophilic attack at either
the acyl or the sulfonyl center. They are
novel inactivators of serine enzymes. The
second-order rate constant for the
inactivation of elastase at pH 6 by N-benzyl-4,4-dimethyl-3-oxo- -sultam is 768 M-1 s-1, which is 103-fold greater than However, in contrast to N-acyl -sultams, which sulfonylate the active site serine residue to form a sulfonate ester, 3
acylation followed by slow deacylation to regenerate the active enzyme.

Item Type: Article
Additional Information: Copyright © 2005 American Chemical Society
Subjects: Q Science > Q Science (General)
Q Science > QD Chemistry
Schools: School of Applied Sciences
School of Applied Sciences > Biomolecular Sciences Research Centre
Related URLs:
References: (1) Baxter, N. J.; Rigoreau, L. J. M.; Laws, A. P.; Page, M. I. J. Am. Chem. Soc. 2000, 112, 3375-3385; J. Chem. Soc., Perkin Trans. 2 1996, 2245- 2246. (2) Hinchliffe, P. S.; Wood, J. M.; Davis, A. M.; Austin, R. P.; Beckett, R. P.; Page, M. I. Org. Biomol. Chem. 2003, 1, 67-80. (3) Page, M. I. Enzyme Inhibition. In ComprehensiVe Medicinal Chemistry; Sammes, P. G., Ed.; Pergamon: Oxford, 1990; Vol. 2, pp 61-87. (4) Metz, W. A.; Peet, N. P. Prog. Inflammation Res. 1999, 9, 853-868. (5) Bode, W.; Meyer, E., Jr.; Powers, J. C. Biochemistry 1989, 28, 1951- 1963. (6) Macdonald, S. J. F. et al. Bioorg. Med. Chem. Lett. 2001, 11, 895-898. (7) Page M. I., Ed. The Chemistry of â-Lactams; Blackie: Glasgow, 1992. (8) (a) Chabin, R.; Green, B. G.; Gale, P.; Maycock, A. L.; Weston, H.; Dorn, C. P.; Finke, P. E.; Hagmann, W. K.; Hale, J. J.; MacCoss, M.; Shah, S. K.; Underwood, D.; Doherty, J. B.; Knight, W. B. Biochemistry 1993, 32, 8970-8980. (b) Beauve, C.; Bouchet, M.; Touillaux, R.; Fastrez, J.; Marchand-Brynaert, J. Tetrahedron 1999, 55, 13301-13320. (9) Wood, J. M.; Page, M. I. Trends Heterocycl. Chem. 2002, 8, 19-34. (10) Page, M. I. Acc. Chem. Res. 2004, 37, 297-303. (11) Macdonald, S. J. F. et al. Bioorg. Med. Chem. Lett. 2001, 11, 243-246. (12) Sykes, N. O.; Macdonald, S. J. F.; Page, M. I. J. Med. Chem. 2002, 45, 2850-2856. (13) Ahmed, N.; Tsang, W. Y.; Page, M. I. Org. Lett. 2004, 6, 201-203. (14) (a) Eriksson, S. O.; Jakobsson M. Acta Pharm. Suec. 1973, 10, 63-74. (b) Matsui, S.; Aida H. J. Chem. Soc., Perkin Trans. 2 1978, 1277- 1280. (15) Wilmouth, R. C.; Westwood, N. J.; Anderson, K.; Brownlee, W.; Claridge, T. D. W.; Clifton, I. J.; Pritchard, G. J.; Aplin, R. T.; Schofield, C. J. Biochemistry 1998, 37, 17506-17513. (16) Firestone, R. A.; Barker, P. L.; Pisano, J. M.; Ashe, B. M.; Dahlgren, M. E. Tetrahedron 1990, 46, 2255-2262. JA050787Z
Depositing User: Sara Taylor
Date Deposited: 08 Feb 2008 09:37
Last Modified: 28 Aug 2021 10:38


Downloads per month over past year

Repository Staff Only: item control page

View Item View Item

University of Huddersfield, Queensgate, Huddersfield, HD1 3DH Copyright and Disclaimer All rights reserved ©